Nevro Corp reports results for the quarter ended in September - Earnings Summary

Nevro

01/11/2023 21:02

* Nevro Corp  NVRO.N  reported a quarterly adjusted loss
of 65
cents​​ per share for the quarter ended in September, lower than
the same quarter last year, when the company reported EPS of
$2.22.  The mean expectation of sixteen analysts for the quarter
was for a loss of 77 cents per share. Wall Street expected
results to range from -91 cents to -44 cents per share.
    * Revenue rose 3.4% to $103.86 million from a year ago;
analysts
expected $96.46 million. 
    * Nevro Corp's reported EPS for the quarter was a loss of 65
cents​.
    * The company reported a quarterly loss of $23.48 million.
    * Nevro Corp shares had fallen by 24.9% this quarter and
lost 63.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 0.1%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 10
"hold" and 4 "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "hold"

Wall Street's median 12-month price target for Nevro Corp is
$22.00 
This summary was machine generated from LSEG data November 1 at
09:02 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -0.77          -0.65          Beat
 Jun. 30 2023      -0.69          -0.69          Met
 Mar. 31 2023      -1.04          -0.98          Beat
 Dec. 31 2022      -0.49          -0.54          Missed